ATS Investor Call
Sanofi was pleased to invite investors and analysts to participate in its ATS Investor Call on Monday, May 22, 2023.
(18h00 – 19h30 CEST / 12:00pm – 1:30pm EDT)
Featuring
![Dietmar Berger, MD, PhD](/optim/dotcom/content-app/events/quaterly-results/2023/q1-2023/Dietmar-Berger_20230427085455.png?size=small)
Dietmar Berger, MD, PhD
Global Head of R&D ad interim
![Bill Sibold](/optim/dotcom/content-app/events/quaterly-results/2022/q4-results-2022/BillSibold_20230417070309.png?size=small)
Bill Sibold
Executive Vice President, Specialty Care
![Naimish Patel, MD](/optim/dotcom/content-app/events/investor-presentation/2022/2022-immunology-investor-event/NaimishPatel_20230405202911.jpg?size=small)
Naimish Patel, MD
Therapeutic Area Head, Immunology & Inflammation
![Elizabeth Laws, PhD](/optim/dotcom/content-app/events/investor-presentation/2023/ats-call/Elizabeth-Law_20230522133718.jpg?size=small)
Elizabeth Laws, PhD
Global Program Head, Dupixent
![Klaus F. Rabe, MD, PhD, FERS](/optim/dotcom/content-app/events/investor-presentation/2023/ats-call/RABE_20230522133724.png?size=small)
Klaus F. Rabe, MD, PhD, FERS
Professor of Medicine, LungenClinic Großhansdorf, Germany
![Surya P. Bhatt, MD, MSPH](/optim/dotcom/content-app/events/investor-presentation/2023/ats-call/Bhatt_20230522133724.png?size=small)
Surya P. Bhatt, MD, MSPH
Associate Professor of Medicine, University of Alabama at Birmingham